Please select the outcome measures that correspond to the clinical trial below.
Title: The Effect of a Group Intervention Program Based on Acceptance and Mindfulness on the Physical and Emotional Well-being of Overweight and Obese Individuals; Mind&Life Project
Brief Summary: The objective of the present study is to evaluate the effect of a 20-week group intervention program based on acceptance and mindfulness in emotional eating, weight loss, physiological parameters and the level of physical exercise, as well as in the quality-of-life and weight self-stigma of overweight and obese people on the short- and medium-term.

Design, participants, and method: A randomized clinical trial comprising a total of 110 overweight or obese (BMI ≥ 25) participants that are receiving medical treatment at Primary Care Centers, 20-65 years, will be included and randomly assigned to standard program (N=55) or standard + intervention program (N=55). The standard program group will receive the treatment as usual (TAU) that comprises 5 sessions (on a monthly basis) that will include a personalized diet and physical exercise recommendations, while the standard + intervention program group will receive the same TAU plus the acceptance and mindfulness-based group intervention program.

At baseline prior to randomization, after the intervention, and seven months after the program has finished anthropometric and body composition data, biochemical data in blood, waist circumference, blood pressure, eating habits, level of physical exercise, general health, emotional eating, quality-of-life, weight self-stigma, experiential avoidance, self-compassion level and mindfulness abilities will be evaluated.

It is hypothesized that the integrated treatment of obesity implementing a group intervention program based on acceptance and mindfulness could help to reduce the emotional eating, enhance weight loss, improve physiological parameters, increase the level of physical exercise, improve the quality of life and reduce the weight self-stigma of overweight and obese individuals.


Options:
A: Change in impulsive eating (TFEQ-R18 "uncontrolled eating" subscale) (From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.)
B: Functional connectivity on fMRI (8 weeks)
C: Point prevalence abstinence at 6 months (6 months after beginning treatment)
D: Changes in Body Mass Index (BMI) measured by Bio-electrical Impedance Analysis (TANITA) (Pretreatment-Posttreatment (5 months)-7 months follow-up); Changes in eating habits estimated by 24h recall and PREDIMED questionnaire (Pretreatment-Posttreatment (5 months)-7 months follow-up); Changes in the level of physical exercise estimated by the International Physical Activity Questionnaire (IPAQ) (Pretreatment-Posttreatment (5 months)-7 months follow-up); Changes in emotional eating estimated by the Dutch Eating Behaviour Questionnaire (DEBQ) (Pretreatment-Posttreatment (5 months)-7 months follow-up); Changes in the quality of life estimated by the Impact of Weight in the Quality of Life-Lite Questionnaire (IWQOL-Lite) (Pretreatment-Posttreatment (5 months)-7 months follow-up); Changes in weight self-stigma estimated by the Weight Self-Stigma Questionnaire (WSSQ) (Pretreatment-Posttreatment (5 months)-7 months follow-up)

Answer: D